These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
444 related items for PubMed ID: 7759159
1. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment. Lykkesfeldt AE, Larsen SS, Briand P. Int J Cancer; 1995 May 16; 61(4):529-34. PubMed ID: 7759159 [Abstract] [Full Text] [Related]
2. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Lykkesfeldt AE, Madsen MW, Briand P. Cancer Res; 1994 Mar 15; 54(6):1587-95. PubMed ID: 8137264 [Abstract] [Full Text] [Related]
3. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells. Coopman P, Garcia M, Brünner N, Derocq D, Clarke R, Rochefort H. Int J Cancer; 1994 Jan 15; 56(2):295-300. PubMed ID: 8314314 [Abstract] [Full Text] [Related]
4. Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness. Larsen SS, Madsen MW, Jensen BL, Lykkesfeldt AE. Int J Cancer; 1997 Sep 17; 72(6):1129-36. PubMed ID: 9378550 [Abstract] [Full Text] [Related]
8. Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780. Hu XF, Veroni M, De Luise M, Wakeling A, Sutherland R, Watts CK, Zalcberg JR. Int J Cancer; 1993 Nov 11; 55(5):873-6. PubMed ID: 8244585 [Abstract] [Full Text] [Related]
10. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells. De Vincenzo R, Scambia G, Benedetti Panici P, Fattorossi A, Bonanno G, Ferlini C, Isola G, Pernisco S, Mancuso S. Int J Cancer; 1996 Nov 04; 68(3):340-8. PubMed ID: 8903476 [Abstract] [Full Text] [Related]
12. Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer. Nicholson RI, Gee JM, Manning DL, Wakeling AE, Montano MM, Katzenellenbogen BS. Ann N Y Acad Sci; 1995 Jun 12; 761():148-63. PubMed ID: 7625718 [No Abstract] [Full Text] [Related]
19. Resistance to different antiestrogens is caused by different multi-factorial changes and is associated with reduced expression of IGF receptor Ialpha. Brockdorff BL, Heiberg I, Lykkesfeldt AE. Endocr Relat Cancer; 2003 Dec 12; 10(4):579-90. PubMed ID: 14713268 [Abstract] [Full Text] [Related]